Excessive blood vessel growth in the retina at the back of the eye is a primary driver of blindness in older individuals. The ...

An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the ...

Researchers have developed a new lipid for delivering mRNA that is safer and more effective than current technologies. By ...

A new mRNA vaccine developed in Japan has been shown to suppress abnormal blood vessel growth in the retina of mice, offering ...

STONY BROOK, NY / ACCESS Newswire / September 23, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), a biotechnology company focused on providing nucleic acid production ...

U.S. defense supports mRNA vaccine development as health department withdraws funding U.S. defense agency backs mRNA vaccine ...

STONY BROOK, NY / ACCESS Newswire / September 23, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production ...

GC Biopharma (006280.KS), a leading South Korean pharmaceutical company, announced today that it has submitted an ...

Moderna has launched its Oxfordshire mRNA Innovation and Technology Centre to produce vaccines, drive research into cancer ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. recently terminated $500 million in federal funding for developing mRNA vaccines, but don’t be fooled into thinking these life-saving too ...

Secretary Kennedy is not beholden to an entrenched medical bureaucracy and certainly not a member of the public health elite. He has approached the role with both deep subject-matter knowledge and a ...

People are still debating whether the mRNA from COVID-19 vaccines remains in the body longer than it should. Some say it ...